Gefitinib treatment was unsuccessful for central diabetes insipidus due to pituitary metastasis of lung adenocarcinoma

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

We herein report a rare case of advanced lung adenocarcinoma with central diabetes insipidus due to pituitary metastasis. Although treatment with gefitinib was dramatically effective, the symptoms of diabetes insipidus did not improve. Radiotherapy for pituitary metastasis was effective to control diabetes insipidus; however, we could not cease the administration of 1-deamino-8-D-arginine vasopressin (DDAVP). It is important for physicians to positively consider radiotherapy for pituitary metastases even if favorable tumor control is achieved with chemotherapy when diabetes insipidus becomes clinically overt. Furthermore, continuous DDAVP administration may be needed to treat central diabetes insipidus.

Cite

CITATION STYLE

APA

Tanaka, S., Hirabayashi, T., Kimoto, M., Hama, M., Hachiya, T., & Gomi, K. (2021). Gefitinib treatment was unsuccessful for central diabetes insipidus due to pituitary metastasis of lung adenocarcinoma. Internal Medicine, 60(7), 1073–1076. https://doi.org/10.2169/INTERNALMEDICINE.5643-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free